| Indicators | Browse All

Anteris Technologies Global Corp. (AVR)

Healthcare | Medical Devices | Toowong, Australia | NasdaqGM
6.52 USD -0.13 (-1.955%) ⇩ (Oct. 13, 2026, 12:37 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 6:43 a.m. EDT

The company presents a classic 'growth at any price' dilemma where massive revenue expansion masks catastrophic financial health. While the 63% revenue growth and strategic backing from Medtronic suggest a promising product roadmap, the fundamentals are currently broken: the business is burning cash at a rate of roughly $86 million annually against only $2.2 million in revenue, resulting in negative ROE and a forward P/E that implies infinite losses. The market is pricing in a turnaround, but the balance sheet is not yet a fortress; it is a liability waiting for capital infusion. The recent $230 million public offering and proposed $200 million deal are critical lifelines, but until profitability turns or cash reserves meaningfully expand relative to burn, the investment case remains speculative. The options market agrees with this caution, showing heavy barriers at $10 and defensive puts at $5, suggesting traders expect a struggle to find a clear trend soon.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.041751
AutoARIMA0.043236
AutoETS0.043410
MSTL0.068057

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 38%
H-stat 0.62
Ljung-Box p 0.000
Jarque-Bera p 0.224
Excess Kurtosis -0.26
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.32
Revenue per Share 0.035
Market Cap 634,671,168
Forward P/E -6.01
Previous Name Anteris Technologies Ltd
Website https://anteristech.com

As of Oct. 10, 2026, 6:43 a.m. EDT: Speculators are positioning for a volatile range-bound scenario rather than a directional breakout. Heavy open interest sits at the $10 strike across expirations, acting as a significant resistance wall, while substantial put volume at the $5 strike suggests a floor. The lack of deep out-of-the-money call volume indicates limited speculative appetite for a rapid surge above current levels.


Info Dump

Attribute Value
52 Week Change 0.45514226
Address1 Toowong Tower
Address2 Level 3, Suite 302 9 Sherwood Road
All Time High 11.055
All Time Low 2.34
Ask 10.57
Ask Size 2
Audit Risk 10
Average Analyst Rating 1.5 - Strong Buy
Average Daily Volume10 Day 1,619,840
Average Daily Volume3 Month 949,579
Average Volume 949,579
Average Volume10Days 1,619,840
Bid 5.95
Bid Size 2
Board Risk 8
Book Value 2.581
City Toowong
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 9
Country Australia
Crypto Tradeable 0
Currency USD
Current Price 6.52
Current Ratio 14.197
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 6.635
Day Low 6.44
Debt To Equity 1.32
Display Name Anteris Technologies Global
Dividend Yield 0.0
Earnings Timestamp End 1,794,513,600
Earnings Timestamp Start 1,794,513,600
Ebitda -104,496,000
Ebitda Margins 0.0
Enterprise To Ebitda -3.778
Enterprise To Revenue 176.109
Enterprise Value 394,836,864
Eps Current Year -1.1915
Eps Forward -1.085
Eps Trailing Twelve Months -1.99
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 8.3394
Fifty Day Average Change -1.8194003
Fifty Day Average Change Percent -0.2181692
Fifty Two Week Change Percent 45.514225
Fifty Two Week High 11.055
Fifty Two Week High Change -4.5350003
Fifty Two Week High Change Percent -0.41022164
Fifty Two Week Low 3.3
Fifty Two Week Low Change 3.22
Fifty Two Week Low Change Percent 0.9757576
Fifty Two Week Range 3.3 - 11.055
Financial Currency USD
First Trade Date Milliseconds 1,734,100,200,000
Float Shares 65,987,184
Forward Eps -1.085
Forward P E -6.0092163
Free Cashflow -51,131,624
Full Exchange Name NasdaqGM
Full Time Employees 174
Fullday Change -0.13000011
Fullday Change Percent -1.9548889
Fullday Price 6.52
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,790,812,800
Gross Margins 0.74977994
Gross Profits 1,681,000
Has Pre Post Market Data 1
Held Percent Insiders 0.16476
Held Percent Institutions 0.71908
Implied Shares Outstanding 97,342,203
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ipo Expected Date 2,024-12-13
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Long Name Anteris Technologies Global Corp.
Market us_market
Market Cap 634,671,168
Market State REGULAR
Max Age 86,400
Message Board Id finmb_24904237
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-13
Net Income To Common -103,564,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 742,633,571
Number Of Analyst Opinions 4
Open 6.61
Operating Cashflow -86,256,000
Operating Margins -30.72052
Overall Risk 9
Payout Ratio 0.0
Phone 61 7 3152 3200
Prev Name Anteris Technologies Ltd
Previous Close 6.65
Price Eps Current Year -5.472094
Price Hint 2
Price To Book 2.5261526
Price To Sales Trailing12 Months 283.08258
Profit Margins 0.0
Quick Ratio 14.02
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.5
Region US
Regular Market Change -0.13000011
Regular Market Change Percent -1.9548889
Regular Market Day High 6.635
Regular Market Day Low 6.44
Regular Market Day Range 6.44 - 6.635
Regular Market Open 6.61
Regular Market Previous Close 6.65
Regular Market Price 6.52
Regular Market Time 1,791,909,450
Regular Market Volume 182,264
Return On Assets -0.42509
Return On Equity -0.74651
Revenue Growth 0.633
Revenue Per Share 0.035
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 97,342,203
Shares Percent Shares Out 0.0684
Shares Short 6,669,292
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 6,973,149
Short Name Anteris Technologies Global Cor
Short Percent Of Float 0.097799994
Short Ratio 9.07
Source Interval 15
State QLD
Symbol AVR
Target High Price 16.0
Target Low Price 10.0
Target Mean Price 14.0
Target Median Price 15.0
Total Cash 256,867,008
Total Cash Per Share 2.636
Total Debt 3,322,000
Total Revenue 2,242,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.99
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 7.30235
Two Hundred Day Average Change -0.78235006
Two Hundred Day Average Change Percent -0.10713675
Type Disp Equity
Volume 182,264
Website https://anteristech.com
Zip 4,066